# Mildronate for Acute Ischemic Stroke

> **NCT01831011** · PHASE2 · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 227 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** mildronate injection
- **DRUG:** cinepazide maleate injection
- **DRUG:** aspirin

## Key facts

- **NCT ID:** NCT01831011
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 227 (ACTUAL)
- **Last updated:** 2013-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831011, "Mildronate for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01831011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*